Under construction – not a live service
Sign in
Taking people in CzechiaNo phase

Helping Adults With COPD or Asthma Use Inhalers Correctly

Tests inhaler technique teaching in adults with COPD or asthma.

Plain-language title generated from the registry record
Registry title: Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

Key facts

Where
Hradec Králové, CzechiaSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with asthma or COPD who use an inhaler, and for health care workers who care for them.

Age
Patients: 18 years or older.
Sex
All sexes can join.
Disease stage
Asthma or COPD already diagnosed under GOLD 2024 or GINA 2024 criteria, with no flare-up (exacerbation) for at least 8 weeks.
Earlier treatment
Patients must have used the same inhaler for at least 3 months.

Main reasons for not taking part

  • Patients in the last stage of any disease (pre-terminal or terminal)
  • Patients who cannot cooperate
  • Patients with major limits in movement or thinking
  • Health care workers with one year or less of work experience

Read by machine on 9 November 2026.

Where in Czechia

  • University Hospital Hradec KraloveHradec Králové, CzechiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Charles University, Czech Republic
Trial code
NCT07183657
Record updated
30 September 2025
Original description
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.Read full original descriptionShow less

Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma

Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.

Inclusion: signed informed consent,; age ≥ 18 years,; previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,; ability to cooperate,; at least 8 weeks without exacerbation,; use of a particular inhaler for at least 3 months; signed informed consent,; completed education in medicine, pharmacy, or nursing,; more than one year of working experience,; care for patients taking inhaled therapy for BA/COPD.

Exclusion: pre-terminal/terminal stage of any disease,; uncooperative patient,; significant limitation of mobility or cognitive functions; HEALTHCARE PROFESSIONALS.

PATIENTS.

ClinicalTrials.gov NCT07183657